Feasibility and safety of the 30-second sit-to-stand test delivered via telehealth: An observational study
- Author(s)
- Bowman, A; Denehy, L; Benjemaa, A; Crowe, J; Bruns, E; Hall, T; Traill, A; Edbrooke, L;
- Details
- Publication Year 2023-01,Volume 15,Issue #1,Page 31-40
- Journal Title
- PM&R
- Publication Type
- Research article
- Abstract
- INTRODUCTION: Exercise testing is essential to determine the safety and efficacy of prescribing exercise. Limited evidence exists to support remotely supervised exercise testing in oncology literature. OBJECTIVE: To determine the feasibility, safety, and convergent validity of the 30-second sit-to-stand test (30STS) delivered via telehealth in an oncology population. Exploratory analyses informed remote test feasibility according to participant and treatment characteristics. DESIGN: Cross-sectional, observational study. SETTING: Telehealth outpatient clinic, tertiary metropolitan oncology hospital. PARTICIPANTS: Thirty-two consecutive outpatients attending telehealth exercise appointments were screened for inclusion. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: A pre-test safety screening questionnaire included the Australia-modified Karnofsky Performance Status (AKPS) and Clinical Frailty Scale (CFS). Following one practice, one 30STS test was completed using a standardized protocol modified for telehealth assessment. Secondary measures: International Physical Activity Questionnaire-Short Form (IPAQ-SF) and pre/post-test Borg Rating of Perceived Exertion (RPE). RESULTS: Thirty participants were deemed as being safe using the screening questionnaire and completed the remote 30STS. Participants were a median (interquartile range [IQR]) 62.5 (51.8 to 66.5) years old, 59% male, 72% undergoing cancer treatment, 34% with metastatic disease, and 56% met current exercise guidelines. Moderate correlation was found between 30STS and IPAQ-SF (rho = 0.49, p = .006), providing evidence of convergent validity. Correlations between 30STS and AKPS (rho = 0.26, p = .161), and CFS (rho = -0.23, p = .214), were fair. Chair-height standardization was poor (range 43 to 60 cm). The clinician could visualize the participant's whole body in 2 of 30 tests. No significant difference in test performance was found for participants with metastatic disease, higher age, or body mass index. No adverse events occurred. CONCLUSION: With screening, the 30STS, performed by telehealth, is a safe and feasible measure of function and lower limb strength. Telehealth exercise testing presents challenges in standardizing the environment and ensuring participant safety. Minimal space and equipment requirements and moderate convergent validity with physical activity provide good clinical utility in this setting.
- Publisher
- Wiley
- Keywords
- Humans; Male; Middle Aged; Aged; Female; Feasibility Studies; Cross-Sectional Studies; *Telemedicine; Physical Therapy Modalities; *Neoplasms/diagnosis/therapy
- Department(s)
- Physiotherapy; Health Services Research
- PubMed ID
- 35138036
- Publisher's Version
- https://doi.org/10.1002/pmrj.12783
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-01-16 04:29:26
Last Modified: 2024-01-16 04:53:14